Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1928089 | 0.98 | TSHR (0.32) | TSHRNFKB1CYP2C19 | |
| SCHEMBL11604688 | 0.90 | — | — | |
| SCHEMBL28849079 | 0.86 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL10170023 | 0.84 | TSHR (0.38) | TSHRNFKB1CYP2C19 | |
| SCHEMBL10170322 | 0.79 | TSHR (0.35) | TSHRNFKB1CYP2C19 | |
| SCHEMBL10171050 | 0.77 | TSHR (0.34) | TSHRNFKB1CYP2C19 | |
| SCHEMBL8476820 | 0.77 | TSHR (0.34) | TSHRNFKB1CYP2C19 | |
| SCHEMBL10170323 | 0.77 | TSHR (0.34) | TSHRNFKB1CYP2C19 | |
| SCHEMBL10171052 | 0.77 | TSHR (0.34) | TSHRNFKB1CYP2C19 | |
| SCHEMBL5413639 | 0.75 | TSHR (0.33) | TSHRNFKB1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105837505-A | Water or oil soluble controllable fluorescent monomer for copolymerization and preparation method thereof | 上海大学 | 2016-08-10 | — | — | CN | claimed |
| CN-105837505-A | Water or oil soluble controllable fluorescent monomer for copolymerization and preparation method thereof | 上海大学 | 2016-08-10 | — | — | CN | disclosed |
| US-8618132-B2 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2013-12-31 | — | — | US | disclosed |
| EP-1558578-B1 | NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM PHARMA (DE) | 2013-03-13 | — | — | EP | disclosed |
| EP-2357173-A1 | New alkyne compounds with MCH-antagonistic activity and medicaments containing them | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2011-08-17 | — | — | EP | disclosed |
| US-20110152234-A1 | Novel Compounds | ASTRAZENECA AB (SE) | 2011-06-23 | — | — | US | disclosed |
| US-7956084-B2 | Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2 | ASTRAZENECA AB (SE) | 2011-06-07 | — | — | US | disclosed |
| EP-1421074-B1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2010-09-29 | — | — | EP | disclosed |
| CN-1732154-B | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM PHARMA | 2010-09-08 | — | — | CN | disclosed |
| US-20090069282-A1 | ALKYNE COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2009-03-12 | — | — | US | disclosed |
| CN-1732154-A | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM PHARMA (DE) | 2006-02-08 | — | — | CN | disclosed |
| US-20040242573-A1 | Novel compounds | ASTRAZENECA AB (SE) | 2004-12-02 | — | — | US | disclosed |
| US-20040209865-A1 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-10-21 | — | — | US | disclosed |
| EP-1421074-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2004-05-26 | — | — | EP | disclosed |
| WO-2003010158-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2003-02-06 | — | — | WO | disclosed |
| EP-0457331-B1 | Piperidine derivatives and antiulcer composition containing the same | MEIJI SEIKA KAISHA (JP) | 1996-11-20 | — | — | EP | disclosed |
| US-5185347-A | PIPERIDINE COMPOUNDS AND ANTIULCER COMPOSITION CONTAINING THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 1993-02-09 | — | — | US | disclosed |
| EP-0457331-A1 | Piperidine derivatives and antiulcer composition containing the same | MEIJI SEIKA KAISHA LTD. (JP) | 1991-11-21 | — | — | EP | disclosed |
| US-4104380-A | Dibenzyl glycolic acid derivatives | WARNER-LAMBERT COMPANY (US) | 1978-08-01 | — | — | US | disclosed |
| US-4076937-A | Dibenzyl glycolic acid derivatives | WARNER-LAMBERT COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242573-A1 | Novel compounds | SULT1E1, TPMT, UGT1A1 | TSHR 529/4885NFKB1 4192/4885CYP2C19 31/4885 |
| US-20090069282-A1 | ALKYNE COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS | MCHR1, MCHR2, GPR119 | TSHR 109/4885NFKB1 2847/4885CYP2C19 3472/4885 |
| US-20040209865-A1 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | MCHR1, MCHR2, NPY1R | TSHR 133/4885NFKB1 3077/4885CYP2C19 3629/4885 |
| US-20110152234-A1 | Novel Compounds | CNR1, ABCG2, CNR2 | TSHR 182/4885NFKB1 3899/4885CYP2C19 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.